RBFOX3 and ischemia: On the other hand, CA1 pyramidal cells of the 200 m/kg YES-10/ischemia group showed strong NeuN immunoreactivity, and the mean number of NeuN immunoreactive CA1 pyramidal cells was significantly higher than that in the 50 and 100 mg/kg YES-10/ischemia groups (Figure 2H,I).